FDA has safety concerns with Merck insomnia drug

Home › FDA has safety concerns with Merck insomnia drug

The Food and Drug Administration on Monday released its review of the company's sleep aid, suvorexant, ahead of a public meeting on Wednesday.

06.10	'Rightmove is my porn' - the addiction to online property search
06.10	Eastern North Pacific Tropical Weather Outlook
06.10	Atlantic Tropical Weather Outlook
05.10	Tropical Storm Milton Public Advisory Number 2
05.10	Hurricane Kirk Graphics
05.10	Hurricane Kirk Forecast Discussion Number 26
05.10	Tropical Storm Milton Graphics
05.10	Hurricane Kirk Wind Speed Probabilities Number 26
More »

je.st